AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 7602359
Drug: Standard treatment:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment: craniospinal radiotherapy (RT) followed by eight cycles of 1‐(2‐chloro‐ethyl)‐3‐cyclohexylnitrosourea (CCNU), vincristine (VCR), and prednisone
Trial: 7602359
Drug: 8-in-1 chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8-in-1 chemotherapy followed by RT and then eight additional cycles of 8-in-1
Trial: 2228353
Drug: 13C-glucose (G)
RxNorm normalized name: Glucose
DrugBank: Dextrose, unspecified form (DB09341)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 13C-glucose (G) ingestion
Trial: 26177812
Drug: Delayed Treatment
RxNorm normalized name: GRANULES, DELAYED RELEASE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed Treatment (control group)
Trial: 23636185
Drug: Anesthetic injection
RxNorm normalized name: Gelato Anesthetic
DrugBank: Benzocaine (DB01086)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Anesthetic injection alone (2 mL 1% lignocaine)
Trial: 21289020
Drug: Intravitreal dexamethasone
RxNorm normalized name: Dexamethasone Intravitreal Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal dexamethasone (0.4 mg/0.1 ml)
Trial: 15918296
Drug: Specific immunotherapy
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific immunotherapy (SIT) with high dose of allergenic extract (Group 2)
Trial: 15918296
Drug: Specific immunotherapy
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific immunotherapy (SIT) with low dose of allergenic extract (Group 1)
Trial: 11783172
Drug: Xialian Yiyou
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xialian Yiyou Capsule (XLYYC)
Trial: 11783172
Drug: Lizhu Dele
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lizhu Dele Capsule (Control)
Trial: 1756252
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human factor VIII (BAY w 6240) administered prophylactically three times a week for 4 weeks
Trial: 1756252
Drug: Plasma-derived factor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plasma-derived factor VIII preparation (pdFVIII)
Trial: 6806184
Drug: Amino acid
RxNorm normalized name: Amino Acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amino acid solution containing 45% branched-chain amino acids (BCAAs)
Trial: 6806184
Drug: Amino acid
RxNorm normalized name: Amino Acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amino acid solution with 10% branched-chain amino acids (BCAAs)
Trial: 31082943
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy (RT) to the prostate
Trial: 25902324
Drug: Manual control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual control (propofol infusion titrated manually)
Trial: 24399452
Drug: Afatinib 20
RxNorm normalized name: afatinib 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Afatinib 20 mg with ritonavir
Trial: 24399452
Drug: Afatinib 40
RxNorm normalized name: afatinib 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Afatinib 40 mg with ritonavir (simultaneous administration)
Trial: 18853093
Drug: Candesartan (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan (8 mg od)
Trial: 17176505
Drug: twice-daily rTMS
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: twice-daily rTMS (left prefrontal cortex, 10 Hz, 110% intensity, 1500 stimuli per session)
Trial: 17176505
Drug: once-daily rTMS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: once-daily rTMS
Trial: 12197262
Drug: Placebo (normal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (normal saline injections; n = 8)
Trial: 7813493
Drug: Penicillin 3
RxNorm normalized name: clemizolpenicillin 300000 UNT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Penicillin 3 x 10(6) U/6 h plus ofloxacin 200 mg twice daily (group A)
Trial: 7813493
Drug: Amoxicillin‐clavulanate 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin‐clavulanate 1 g/6 h plus erythromycin 1 g/8 h (group B)
Trial: 409028
Drug: Progestogen-only oral
RxNorm normalized name: vaginal ring with progestogen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Progestogen-only oral contraceptives
Trial: 31838367
Drug: Benzodiazepine intake
RxNorm normalized name: 1,3-dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one
DrugBank: Nitrazepam (DB01595)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benzodiazepine intake factors (length of use and dose)
Trial: 17522618
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid (1 mg)
Trial: 27467700
Drug: Focal psychodynamic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Focal psychodynamic therapy (FPT)
Trial: 27609525
Drug: Enhanced cognitive-behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enhanced cognitive-behavioural therapy (CBT-E)
Trial: 27609525
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual (TAU-O)
Trial: 25056510
Drug: Low-dose hydrocortisone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose hydrocortisone therapy (steroid group)
Trial: 11705307
Drug: Alitretinoin gel
RxNorm normalized name: Alitretinoin
DrugBank: Alitretinoin (DB00523)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alitretinoin gel 0.1%
Trial: 9440643
Drug: Sorbitol (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sorbitol (5 g)
Trial: 10187002
Drug: Intravenous tramadol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous tramadol
Trial: 12515745
Drug: Effective nCPAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Effective nCPAP treatment
Trial: 10500312
Drug: Urokinase (UK)
DrugBank: Urokinase (DB00013)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Urokinase (UK) high-dose group (18,000 IU/kg, max 1.5 million IU)
Trial: 24374502
Drug: ORV-116E vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ORV-116E vaccine
Trial: 24374502
Drug: Higher dose
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher dose of ORV-116E vaccine
Trial: 20542512
Drug: n‐3 PUFA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n‐3 PUFA ethyl ester capsules
Trial: 19025504
Drug: Early physiotherapy
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early physiotherapy intervention (education, reassurance, pain management, mobility training, interferential therapy, walking training, and walking aids)
Trial: 14767409
Drug: Creatine supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine supplementation (20 g/day for 1 week, then 3 g/day for 2 weeks)
Trial: 15836828
Drug: Ulinastatin treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ulinastatin treatment (100 kU intravenously drip, once every 8 hours for 5 days)
Trial: 29699021
Drug: Ulinastatin treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ulinastatin treatment
Trial: 15836828
Drug: Ulinastatin treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ulinastatin treatment and Routine treatment
Trial: 1974675
Drug: Tulobuterol 2
RxNorm normalized name: tulobuterol 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tulobuterol 2 mg tablets taken twice daily for 12 weeks
Trial: 21743091
Drug: Receiving assistance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Receiving assistance with activities of daily living
Trial: 22781526
Drug: Dexmedetomidine 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine 0.5 µg × kg(‐1)× h(‐1)
Trial: 22781526
Drug: Dexmedetomidine 0.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine 0.75 µg × kg(‐1)× h(‐1)
Trial: 22781526
Drug: Dexmedetomidine 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine 1.0 µg × kg(‐1)× h(‐1)
Trial: 22781526
Drug: Dexmedetomidine (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine (all doses) vs Control
Trial: 10454704
Drug: Placebo or
RxNorm normalized name: placebo ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo or no maintenance treatment
Trial: 7561123
Drug: Candidate HIV‐1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candidate HIV‐1 recombinant envelope subunit vaccines
Trial: 2180792
Drug: cisapride 0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cisapride 0.15 mg/kg intravenously
Trial: 2180792
Drug: cisapride 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cisapride 0.2 mg/kg tid for 4 weeks
Trial: 396057
Drug: BCG vaccines
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCG vaccines
Trial: 28492860
Drug: Aflibercept, 2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aflibercept, 2.0 mg
Trial: 28492860
Drug: Bevacizumab, 1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bevacizumab, 1.25 mg
Trial: 30676635
Drug: All anti-VEGF
RxNorm normalized name: Anti-VEGF monoclonal antibody
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: All anti-VEGF treatments
Trial: 9766832
Drug: Lidocaine topical
RxNorm normalized name: lidocaine topical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine topical anesthetic
Trial: 26210387
Drug: SRP and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SRP and PerioCol™CG (controlled-release device containing chlorhexidine)
Trial: 27402391
Drug: Saxagliptin 5
RxNorm normalized name: sAXagliptin 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saxagliptin 5 mg/day
Trial: 23638466
Drug: Glipizide titrated
RxNorm normalized name: Glipizide
DrugBank: Glipizide (DB01067)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glipizide titrated from 5 to 20 mg/day (mean dose 15 mg/day)
Trial: 6775304
Drug: Topical nitroglycerin
RxNorm normalized name: nitroglycerin Topical Ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical nitroglycerin gel (15 to 30 mg)
Trial: 6775304
Drug: Oral slow-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral slow-release nitroglycerin compound (Lénitral) 7.5 mg
Trial: 12467334
Drug: Calcipotriene cream
RxNorm normalized name: Calcipotriene Cream
DrugBank: Calcipotriol (DB02300)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcipotriene cream plus PUVA radiation
Trial: 30876831
Drug: Pembrolizumab (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pembrolizumab (2 mg/kg every 3 weeks or 10 mg/kg every 2 or 3 weeks)
Trial: 15292315
Drug: Raloxifene (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raloxifene (60 mg/d)
Trial: 19088803
Drug: Enalaprilat (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalaprilat (50 microg x min‐1 intracoronary infusion)
Trial: 12105241
Drug: Persistent proteinuria
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Persistent proteinuria (UP) >1.0 g/24 h at diagnosis
Trial: 10202242
Drug: Both Gd
RxNorm normalized name: Gd-HPDO3A
DrugBank: Gadoteridol (DB00597)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Both Gd doses after clinical relapses
Trial: 121483
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (without IPPB therapy)
Trial: 28991063
Drug: Ropivacaine (0.625,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine (0.625, 1.0, 1.5, 2.5, 4.0, or 6.25 mg)
Trial: 28991063
Drug: Levobupivacaine (0.625,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levobupivacaine (0.625, 1.0, 1.5, 2.5, 4.0, or 6.25 mg)
Trial: 12823153
Drug: Omeprazole capsule
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole capsule 20 mg
Trial: 12823153
Drug: Omeprazole MUPS
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole MUPS tablet 20 mg
Trial: 8777954
Drug: Inhaled heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled heparin (1,000 U.kg‐1)
Trial: 27824680
Drug: Azilsartan (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azilsartan (20 mg)
Trial: 19918859
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate (ISDN) ointment
Trial: 19367171
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine (two-thirds of the total daily insulin dose required) subcutaneous administration with 5% dextrose solution infusion
Trial: 19367171
Drug: Glucose-insulin-potassium (GIK)
RxNorm normalized name: glucose / potassium chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose-insulin-potassium (GIK) infusion (125 ml/h)
Trial: 16688803
Drug: Rabeprazole (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole (20 mg bid)
Trial: 11309553
Drug: Venlafaxine 37.5
RxNorm normalized name: venlafaxine 37.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venlafaxine 37.5 mg orally, 4 times with 12-hour intervals
Trial: 2568202
Drug: bromazepam 1.5
RxNorm normalized name: bromazepam 1.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bromazepam 1.5 mg bidaily (B)
Trial: 2568202
Drug: labetalol 100
RxNorm normalized name: HCTZ 25/LABETALOL 100MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: labetalol 100 mg bidaily (L)
Trial: 31124504
Drug: Conventional laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional laser treatment (control group)
Trial: 25065959
Drug: Low-dose (LD)
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose (LD) PLT prophylaxis
Trial: 23062105
Drug: Sonic Irrigation
RxNorm normalized name: Ellis Tonic
DrugBank: Zinc sulfate, unspecified form (DB14548)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sonic Irrigation (SI) with 0.08 taper
Trial: 21996202
Drug: mTOR inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mTOR inhibitors with steroids
Trial: 21996202
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (calcineurin inhibitor, mycophenolate mofetil or sodium plus steroids)
Trial: 16508333
Drug: 10 IR
RxNorm normalized name: Yellow 10 Iron Oxide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 IR solution
Trial: 16508333
Drug: 100 IR
RxNorm normalized name: Gentaved 100 Irrigation Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 IR solution
Trial: 16508333
Drug: 300 IR
RxNorm normalized name: ORALAIR 300 IR TAB,SL PKT 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 IR solution
Trial: 2105872
Drug: Triphasil (0.075
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triphasil (0.075 mg LNG, 0.040 mg EE2)
Trial: 2105872
Drug: Trinordiol (0.075
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trinordiol (0.075 mg LNG, 0.040 mg EE2)
Trial: 2105872
Drug: All formulations
RxNorm normalized name: Novel Influenza-H1N1-09, all formulations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All formulations (Triphasil, Trinordiol, Hydroalcoholic solution)
Trial: 373956
Drug: Treatment center
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment center selection criteria
Trial: 6833462
Drug: 2‐4 mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2‐4 mg micronized estradiol given orally
Trial: 6833462
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg estradiol orally
Trial: 6833462
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg estradiol applied cutaneously
Trial: 25040840
Drug: 0.2% plain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2% plain ropivacaine 0.75 ml·kg(‐1)
Trial: 25040840
Drug: dexmedetomidine 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dexmedetomidine 0.5 μg·kg(‐1) with 0.2% ropivacaine 0.75 ml·kg(‐1)
Trial: 25040840
Drug: dexmedetomidine 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dexmedetomidine 1.0 μg·kg(‐1) with 0.2% ropivacaine 0.75 ml·kg(‐1)
Trial: 25040840
Drug: dexmedetomidine 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dexmedetomidine 1.5 μg·kg(‐1) with 0.2% ropivacaine 0.75 ml·kg(‐1)
Trial: 20219398
Drug: Exposure in
RxNorm normalized name: Bacillus anthracis strain V770-NP1-R antigens
DrugBank: Anthrax vaccine (DB11003)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exposure in vivo treatment for back pain patients with low or moderate levels of catastrophizing
Trial: 20219398
Drug: Exposure in
RxNorm normalized name: Bacillus anthracis strain V770-NP1-R antigens
DrugBank: Anthrax vaccine (DB11003)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exposure in vivo treatment for back pain patients with high levels of catastrophizing
Trial: 17347859
Drug: Outox (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Outox (250 ml)
Trial: 2135068
Drug: Placebo (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (250 ml)
Trial: 1282183
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg nicorandil
Trial: 2137279
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg nicorandil
Trial: 7433476
Drug: Oxymetazoline (0.025%)
RxNorm normalized name: Oxymethazoline
DrugBank: Oxymetazoline (DB00935)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxymetazoline (0.025%) ophthalmic solution, 2 drops 4 times daily
Trial: 31651367
Drug: Psychodynamic case
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Psychodynamic case formulations made by experienced clinicians using simple experience-near language
Trial: 29698983
Drug: Resistance training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resistance training (supervised thrice-weekly for 16 weeks)
Trial: 20172547
Drug: Ketorolac and
RxNorm normalized name: Ketorolac and phenylephrine only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac and acetaminophen
Trial: 17954514
Drug: Intramuscular haloperidol
RxNorm normalized name: Haloperidol
DrugBank: Haloperidol (DB00502)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular haloperidol plus promethazine
Trial: 12829647
Drug: NN2211 (7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NN2211 (7.5 micro g/kg)
Trial: 9892294
Drug: Both interventions
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both interventions (day treatment and enhanced standard care)
Trial: 31290996
Drug: Dasatinib (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dasatinib (100 mg orally twice daily) plus Bevacizumab (10 mg/kg intravenously on day 1 of each 14-day cycle)
Trial: 31290996
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus Bevacizumab (10 mg/kg intravenously on day 1 of each 14-day cycle)
Trial: 25274861
Drug: Intravenous adenosine
RxNorm normalized name: Adenosine
DrugBank: Adenosine phosphate (DB00131)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous adenosine (IV adenosine)
Trial: 17229423
Drug: EMLA cream
RxNorm normalized name: LIDOCAINE 25 mg in 1 g / PRILOCAINE 25 mg in 1 g TOPICAL CREAM [Emla Cream]
DrugBank: Prilocaine (DB00750)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EMLA cream applied for 40 minutes
Trial: 15179345
Drug: Conventional anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional anesthesia after shifting to insulin (I‐CA)
Trial: 15179345
Drug: Conventional anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional anesthesia plus isoflurane after shifting to insulin (I‐ISO)
Trial: 15179345
Drug: Conventional anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional anesthesia plus isoflurane (G‐ISO)
Trial: 12507972
Drug: Vitamin B(12)
RxNorm normalized name: VITAMIN B
DrugBank: Inositol (DB13178)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin B(12) (0.4 mg), folic acid (0.8 mg), and vitamin B(6) (40 mg)
Trial: 9637646
Drug: Epidural saline-intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural saline-intravenous fentanyl (20 microg/h)
Trial: 9637646
Drug: Epidural saline-intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural saline-intravenous saline (control)
Trial: 9637646
Drug: Intravenous fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous fentanyl (20 microg/h)
Trial: 3189722
Drug: Topical beclomethasone
RxNorm normalized name: beclomethasone Topical Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical beclomethasone dipropionate 100 micrograms in each nostril twice daily for 4 weeks
Trial: 3189722
Drug: Diprospan (betamethasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diprospan (betamethasone dipropionate 5 mg and betamethasone disodium phosphate 2 mg per ml) injection
Trial: 24815326
Drug: Aramchol 300
RxNorm normalized name: Aramchol
DrugBank: Aramchol (DB11860)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aramchol 300 mg/day